These results define high rates of mitochondrial translation enabled by Tfam expression as an essential requirement for the development of B cell lymphoma and show the therapeutic potential of POLRMT and mitochondrial translation inhibition in human disease. Here, TFAM is linked to B-cell non-Hodgkin lymphoma.